| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G | 2021-11-24 | Newtyn Management, LLC | Flexion Therapeutics Inc | 4,400,000 | 8.7% | EDGAR |
| SC 13G/A | 2021-11-09 | WASATCH ADVISORS INC | Flexion Therapeutics Inc | - | - | EDGAR |
| SC 13G/A | 2021-05-10 | MILLER VALUE PARTNERS, LLC | Flexion Therapeutics Inc | 154,925 | 0.3% | EDGAR |
| SC 13G/A | 2021-02-16 | MILLER VALUE PARTNERS, LLC | Flexion Therapeutics Inc | 4,196,100 | 8.5% | EDGAR |
| SC 13G/A | 2021-02-16 | Capital World Investors | Flexion Therapeutics Inc | 3,823,000 | 7.8% | EDGAR |
| SC 13G/A | 2021-02-11 | WASATCH ADVISORS INC | Flexion Therapeutics Inc | - | - | EDGAR |
| SC 13G | 2021-02-10 | STATE STREET CORP | Flexion Therapeutics Inc | - | 5.1% | EDGAR |
| SC 13G | 2021-02-10 | Artisan Partners Limited Partnership | Flexion Therapeutics Inc | 3,076,029 | 6.2% | EDGAR |
| SC 13G/A | 2021-01-29 | BlackRock Inc. | Flexion Therapeutics Inc | 4,339,324 | 8.8% | EDGAR |
| SC 13D/A | 2021-01-26 | Versant Venture Capital III, L.P. | Flexion Therapeutics Inc | 994,129 | 2.0% | EDGAR |
| SC 13G/A | 2020-02-14 | STATE STREET CORP | Flexion Therapeutics Inc | - | 4.4% | EDGAR |
| SC 13G/A | 2020-02-14 | MILLER VALUE PARTNERS, LLC | Flexion Therapeutics Inc | 4,932,875 | 12.9% | EDGAR |
| SC 13G/A | 2020-02-14 | GILDER GAGNON HOWE & CO LLC | Flexion Therapeutics Inc | 429,255 | 1.1% | EDGAR |
| SC 13G/A | 2020-02-14 | Capital World Investors | Flexion Therapeutics Inc | 2,510,700 | 6.5% | EDGAR |
| SC 13G | 2020-02-10 | WASATCH ADVISORS INC | Flexion Therapeutics Inc | - | - | EDGAR |
| SC 13G/A | 2020-02-05 | BlackRock Inc. | Flexion Therapeutics Inc | 3,064,652 | 8.0% | EDGAR |
| SC 13G/A | 2019-05-10 | WELLS FARGO & COMPANY/MN | Flexion Therapeutics Inc | 865,072 | 2.3% | EDGAR |
| SC 13G/A | 2019-04-23 | MILLER VALUE PARTNERS, LLC | Flexion Therapeutics Inc | 4,109,720 | 10.8% | EDGAR |
| SC 13G/A | 2019-02-15 | GILDER GAGNON HOWE & CO LLC | Flexion Therapeutics Inc | 2,389,960 | 6.3% | EDGAR |
| SC 13G/A | 2019-02-14 | MILLER VALUE PARTNERS, LLC | Flexion Therapeutics Inc | 3,113,390 | 8.2% | EDGAR |